Skip to main content
Erschienen in: Urolithiasis 2/2012

01.04.2012 | Review

Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome?

verfasst von: Saeed R. Khan

Erschienen in: Urolithiasis | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Epidemiological studies have provided the evidence for association between nephrolithiasis and a number of cardiovascular diseases including hypertension, diabetes, chronic kidney disease, metabolic syndrome. Many of the co-morbidities may not only lead to stone disease but also be triggered by it. Nephrolithiasis is a risk factor for development of hypertension and have higher prevalence of diabetes mellitus and some hypertensive and diabetic patients are at greater risk for stone formation. An analysis of the association between stone disease and other simultaneously appearing disorders, as well as factors involved in their pathogenesis, may provide an insight into stone formation and improved therapies for stone recurrence and prevention. It is our hypothesis that association between stone formation and development of co-morbidities is a result of certain common pathological features. Review of the recent literature indicates that production of reactive oxygen species (ROS) and development of oxidative stress (OS) may be such a common pathway. OS is a common feature of all cardiovascular diseases (CVD) including hypertension, diabetes mellitus, atherosclerosis and myocardial infarct. There is increasing evidence that ROS are also produced during idiopathic calcium oxalate (CaOx) nephrolithiasis. Both tissue culture and animal model studies demonstrate that ROS are produced during interaction between CaOx/calcium phosphate (CaP) crystals and renal epithelial cells. Clinical studies have also provided evidence for the development of oxidative stress in the kidneys of stone forming patients. Renal disorders which lead to OS appear to be a continuum. Stress produced by one disorder may trigger the other under the right circumstances.
Literatur
1.
Zurück zum Zitat Pearle MS, Calhoun EA, Curhan GC (2005) Urologic diseases in America project: urolithiasis. J Urol 173:848PubMedCrossRef Pearle MS, Calhoun EA, Curhan GC (2005) Urologic diseases in America project: urolithiasis. J Urol 173:848PubMedCrossRef
2.
Zurück zum Zitat Stamatelou KK, Francis ME, Jones CA et al (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817PubMedCrossRef Stamatelou KK, Francis ME, Jones CA et al (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817PubMedCrossRef
3.
Zurück zum Zitat Soucie JM, Coates RJ, McClellan W et al (1996) Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am J Epidemiol 143:487PubMed Soucie JM, Coates RJ, McClellan W et al (1996) Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am J Epidemiol 143:487PubMed
4.
Zurück zum Zitat Brikowski TH, Lotan Y, Pearle MS (2008) Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci USA 105:9841PubMedCrossRef Brikowski TH, Lotan Y, Pearle MS (2008) Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci USA 105:9841PubMedCrossRef
5.
Zurück zum Zitat Obligado SH, Goldfarb DS (2008) The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens 21:257PubMedCrossRef Obligado SH, Goldfarb DS (2008) The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens 21:257PubMedCrossRef
6.
Zurück zum Zitat Lieske JC, de la Vega LS, Gettman MT et al (2006) Diabetes mellitus and the risk of urinary tract stones: a population-based case–control study. Am J Kidney Dis 48:897PubMedCrossRef Lieske JC, de la Vega LS, Gettman MT et al (2006) Diabetes mellitus and the risk of urinary tract stones: a population-based case–control study. Am J Kidney Dis 48:897PubMedCrossRef
7.
Zurück zum Zitat Jeong IG, Kang T, Bang JK et al (2011) Association between metabolic syndrome and the presence of kidney stones in a screened population. Am J Kidney Dis 58:383PubMedCrossRef Jeong IG, Kang T, Bang JK et al (2011) Association between metabolic syndrome and the presence of kidney stones in a screened population. Am J Kidney Dis 58:383PubMedCrossRef
8.
Zurück zum Zitat Saucier NA, Sinha MK, Liang KV et al (2009) Risk factors for CKD in persons with kidney stones: a case-control study in Olmsted County, Minnesota. Am J Kidney Dis 55:61PubMedCrossRef Saucier NA, Sinha MK, Liang KV et al (2009) Risk factors for CKD in persons with kidney stones: a case-control study in Olmsted County, Minnesota. Am J Kidney Dis 55:61PubMedCrossRef
9.
Zurück zum Zitat Coe FL, Evan AP, Worcester EM et al (2010) Three pathways for human kidney stone formation. Urol Res 38:147PubMedCrossRef Coe FL, Evan AP, Worcester EM et al (2010) Three pathways for human kidney stone formation. Urol Res 38:147PubMedCrossRef
10.
Zurück zum Zitat Johri N, Cooper B, Robertson W et al (2010) An update and practical guide to renal stone management. Nephron Clin Pract 116:c159PubMedCrossRef Johri N, Cooper B, Robertson W et al (2010) An update and practical guide to renal stone management. Nephron Clin Pract 116:c159PubMedCrossRef
11.
Zurück zum Zitat Tibblin G (1965) A population study of 50-year-old men. An analysis of the non-participation group. Acta Med Scand 178:453PubMedCrossRef Tibblin G (1965) A population study of 50-year-old men. An analysis of the non-participation group. Acta Med Scand 178:453PubMedCrossRef
12.
Zurück zum Zitat Cirillo M, Laurenzi M (1988) Elevated blood pressure and positive history of kidney stones: results from a population-based study. J Hypertens Suppl 6:S485PubMed Cirillo M, Laurenzi M (1988) Elevated blood pressure and positive history of kidney stones: results from a population-based study. J Hypertens Suppl 6:S485PubMed
13.
Zurück zum Zitat Cappuccio FP, Strazzullo P, Mancini M (1990) Kidney stones and hypertension: population based study of an independent clinical association. BMJ 300:1234PubMedCrossRef Cappuccio FP, Strazzullo P, Mancini M (1990) Kidney stones and hypertension: population based study of an independent clinical association. BMJ 300:1234PubMedCrossRef
14.
Zurück zum Zitat Kim YJ, Park MS, Kim WT et al (2010) Hypertension influences recurrent stone formation in nonobese stone formers. Urology 77:1059PubMedCrossRef Kim YJ, Park MS, Kim WT et al (2010) Hypertension influences recurrent stone formation in nonobese stone formers. Urology 77:1059PubMedCrossRef
15.
Zurück zum Zitat Cappuccio FP, Siani A, Barba G et al (1999) A prospective study of hypertension and the incidence of kidney stones in men. J Hypertens 17:1017PubMedCrossRef Cappuccio FP, Siani A, Barba G et al (1999) A prospective study of hypertension and the incidence of kidney stones in men. J Hypertens 17:1017PubMedCrossRef
16.
Zurück zum Zitat Strazzullo P, Barba G, Vuotto P et al (2001) Past history of nephrolithiasis and incidence of hypertension in men: a reappraisal based on the results of the Olivetti Prospective Heart Study. Nephrol Dial Transplant 16:2232PubMedCrossRef Strazzullo P, Barba G, Vuotto P et al (2001) Past history of nephrolithiasis and incidence of hypertension in men: a reappraisal based on the results of the Olivetti Prospective Heart Study. Nephrol Dial Transplant 16:2232PubMedCrossRef
17.
Zurück zum Zitat Madore F, Stampfer MJ, Rimm EB et al (1998) Nephrolithiasis and risk of hypertension. Am J Hypertens 11:46PubMedCrossRef Madore F, Stampfer MJ, Rimm EB et al (1998) Nephrolithiasis and risk of hypertension. Am J Hypertens 11:46PubMedCrossRef
18.
Zurück zum Zitat Madore F, Stampfer MJ, Willett WC et al (1998) Nephrolithiasis and risk of hypertension in women. Am J Kidney Dis 32:802PubMedCrossRef Madore F, Stampfer MJ, Willett WC et al (1998) Nephrolithiasis and risk of hypertension in women. Am J Kidney Dis 32:802PubMedCrossRef
19.
Zurück zum Zitat Borghi L, Meschi T, Guerra A et al (1999) Essential arterial hypertension and stone disease. Kidney Int 55:2397PubMedCrossRef Borghi L, Meschi T, Guerra A et al (1999) Essential arterial hypertension and stone disease. Kidney Int 55:2397PubMedCrossRef
20.
Zurück zum Zitat Stoller ML, Low RK, Shami GS et al (1996) High resolution radiography of cadaveric kidneys: unraveling the mystery of Randall’s plaque formation. J Urol 156:1263PubMedCrossRef Stoller ML, Low RK, Shami GS et al (1996) High resolution radiography of cadaveric kidneys: unraveling the mystery of Randall’s plaque formation. J Urol 156:1263PubMedCrossRef
21.
Zurück zum Zitat Wexler BC, McMurtry JP (1981) Kidney and bladder calculi in spontaneously hypertensive rats. Br J Exp Pathol 62:369PubMed Wexler BC, McMurtry JP (1981) Kidney and bladder calculi in spontaneously hypertensive rats. Br J Exp Pathol 62:369PubMed
22.
Zurück zum Zitat Koletsky S (1975) Pathologic findings and laboratory data in a new strain of obese hypertensive rats. Am J Pathol 80:129PubMed Koletsky S (1975) Pathologic findings and laboratory data in a new strain of obese hypertensive rats. Am J Pathol 80:129PubMed
23.
Zurück zum Zitat Domingos F, Serra A (2010) Nephrolithiasis is associated with an increased prevalence of cardiovascular disease. Nephrol Dial Transplant 26:864PubMedCrossRef Domingos F, Serra A (2010) Nephrolithiasis is associated with an increased prevalence of cardiovascular disease. Nephrol Dial Transplant 26:864PubMedCrossRef
24.
Zurück zum Zitat Akoudad S, Szklo M, McAdams MA et al (2010) Correlates of kidney stone disease differ by race in a multi-ethnic middle-aged population: the ARIC study. Prev Med 51:416PubMedCrossRef Akoudad S, Szklo M, McAdams MA et al (2010) Correlates of kidney stone disease differ by race in a multi-ethnic middle-aged population: the ARIC study. Prev Med 51:416PubMedCrossRef
25.
Zurück zum Zitat Gillen DL, Coe FL, Worcester EM (2005) Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis 46:263PubMedCrossRef Gillen DL, Coe FL, Worcester EM (2005) Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis 46:263PubMedCrossRef
26.
Zurück zum Zitat Breslau NA, Pak CY (1982) Endocrine aspects of nephrolithiasis. Spec Top Endocrinol Metab 3:57PubMed Breslau NA, Pak CY (1982) Endocrine aspects of nephrolithiasis. Spec Top Endocrinol Metab 3:57PubMed
27.
Zurück zum Zitat Liu JG, Hu M, He XQ (1989) Risk factors for the formation of urinary calcium-containing stones in diabetics. Zhonghua Nei Ke Za Zhi 28:649PubMed Liu JG, Hu M, He XQ (1989) Risk factors for the formation of urinary calcium-containing stones in diabetics. Zhonghua Nei Ke Za Zhi 28:649PubMed
28.
Zurück zum Zitat Meydan N, Barutca S, Caliskan S et al (2003) Urinary stone disease in diabetes mellitus. Scand J Urol Nephrol 37:64PubMedCrossRef Meydan N, Barutca S, Caliskan S et al (2003) Urinary stone disease in diabetes mellitus. Scand J Urol Nephrol 37:64PubMedCrossRef
29.
Zurück zum Zitat Taylor EN, Stampfer MJ, Curhan GC (2005) Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 68:1230PubMedCrossRef Taylor EN, Stampfer MJ, Curhan GC (2005) Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 68:1230PubMedCrossRef
30.
Zurück zum Zitat Pak CY, Sakhaee K, Moe O et al (2003) Biochemical profile of stone-forming patients with diabetes mellitus. Urology 61:523PubMedCrossRef Pak CY, Sakhaee K, Moe O et al (2003) Biochemical profile of stone-forming patients with diabetes mellitus. Urology 61:523PubMedCrossRef
31.
Zurück zum Zitat Daudon M, Traxer O, Conort P et al (2006) Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol 17:2026PubMedCrossRef Daudon M, Traxer O, Conort P et al (2006) Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol 17:2026PubMedCrossRef
32.
Zurück zum Zitat Zimmerer T, Weiss C, Hammes HP et al (2009) Evaluation of urolithiasis: a link between stone formation and diabetes mellitus? Urol Int 82:350PubMedCrossRef Zimmerer T, Weiss C, Hammes HP et al (2009) Evaluation of urolithiasis: a link between stone formation and diabetes mellitus? Urol Int 82:350PubMedCrossRef
33.
Zurück zum Zitat Eisner BH, Porten SP, Bechis SK et al (2010) Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. J Urol 183:2244PubMedCrossRef Eisner BH, Porten SP, Bechis SK et al (2010) Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. J Urol 183:2244PubMedCrossRef
34.
Zurück zum Zitat Hamano S, Nakatsu H, Suzuki N et al (2005) Kidney stone disease and risk factors for coronary heart disease. Int J Urol 12:859PubMedCrossRef Hamano S, Nakatsu H, Suzuki N et al (2005) Kidney stone disease and risk factors for coronary heart disease. Int J Urol 12:859PubMedCrossRef
35.
Zurück zum Zitat Ljunghall S, Hedstrand H (1976) Renal stones and coronary heart disease. Acta Med Scand 199:481PubMedCrossRef Ljunghall S, Hedstrand H (1976) Renal stones and coronary heart disease. Acta Med Scand 199:481PubMedCrossRef
36.
Zurück zum Zitat Rule AD, Bergstralh EJ, Melton LJ 3rd et al (2009) Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 4:804PubMedCrossRef Rule AD, Bergstralh EJ, Melton LJ 3rd et al (2009) Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 4:804PubMedCrossRef
37.
Zurück zum Zitat Rule AD, Roger VL, Melton LJ 3rd et al (2010) Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol 21:1641PubMedCrossRef Rule AD, Roger VL, Melton LJ 3rd et al (2010) Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol 21:1641PubMedCrossRef
38.
Zurück zum Zitat Reiner AP, Kahn A, Eisner BH et al (2011) Kidney stones and subclinical atherosclerosis in young adults: the CARDIA study. J Urol 185:920PubMedCrossRef Reiner AP, Kahn A, Eisner BH et al (2011) Kidney stones and subclinical atherosclerosis in young adults: the CARDIA study. J Urol 185:920PubMedCrossRef
39.
Zurück zum Zitat Gupta M, Bolton DM, Gupta PN et al (1994) Improved renal function following aggressive treatment of urolithiasis and concurrent mild to moderate renal insufficiency. J Urol 152:1086PubMed Gupta M, Bolton DM, Gupta PN et al (1994) Improved renal function following aggressive treatment of urolithiasis and concurrent mild to moderate renal insufficiency. J Urol 152:1086PubMed
40.
Zurück zum Zitat Goel MC, Ahlawat R, Kumar M et al (1997) Chronic renal failure and nephrolithiasis in a solitary kidney: role of intervention. J Urol 157:1574PubMedCrossRef Goel MC, Ahlawat R, Kumar M et al (1997) Chronic renal failure and nephrolithiasis in a solitary kidney: role of intervention. J Urol 157:1574PubMedCrossRef
41.
Zurück zum Zitat Gillen DL, Worcester EM, Coe FL (2005) Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int 67:685PubMedCrossRef Gillen DL, Worcester EM, Coe FL (2005) Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int 67:685PubMedCrossRef
42.
Zurück zum Zitat Vupputuri S, Soucie JM, McClellan W et al (2004) History of kidney stones as a possible risk factor for chronic kidney disease. Ann Epidemiol 14:222PubMedCrossRef Vupputuri S, Soucie JM, McClellan W et al (2004) History of kidney stones as a possible risk factor for chronic kidney disease. Ann Epidemiol 14:222PubMedCrossRef
43.
Zurück zum Zitat Ingsathit A, Thakkinstian A, Chaiprasert A et al (2010) Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant 25:1567PubMedCrossRef Ingsathit A, Thakkinstian A, Chaiprasert A et al (2010) Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant 25:1567PubMedCrossRef
44.
Zurück zum Zitat Meneses JA, Lucas FM, Assuncao FC et al (2011) The impact of metaphylaxis of kidney stone disease in the renal function at long term in active kidney stone formers patients. Urol Res [Epub ahead of print] Meneses JA, Lucas FM, Assuncao FC et al (2011) The impact of metaphylaxis of kidney stone disease in the renal function at long term in active kidney stone formers patients. Urol Res [Epub ahead of print]
45.
Zurück zum Zitat Dandona P, Aljada A, Chaudhuri A et al (2005) Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111:1448PubMedCrossRef Dandona P, Aljada A, Chaudhuri A et al (2005) Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111:1448PubMedCrossRef
46.
Zurück zum Zitat Curhan GC, Willett WC, Rimm EB et al (1998) Body size and risk of kidney stones. J Am Soc Nephrol 9:1645PubMed Curhan GC, Willett WC, Rimm EB et al (1998) Body size and risk of kidney stones. J Am Soc Nephrol 9:1645PubMed
47.
Zurück zum Zitat Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293:455PubMedCrossRef Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293:455PubMedCrossRef
48.
Zurück zum Zitat West B, Luke A, Durazo-Arvizu RA et al (2008) Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988–1994. Am J Kidney Dis 51:741PubMedCrossRef West B, Luke A, Durazo-Arvizu RA et al (2008) Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988–1994. Am J Kidney Dis 51:741PubMedCrossRef
49.
Zurück zum Zitat Ando R, Suzuki S, Nagaya T et al (2011) Impact of insulin resistance, insulin and adiponectin on kidney stones in the Japanese population. Int J Urol 18:131PubMedCrossRef Ando R, Suzuki S, Nagaya T et al (2011) Impact of insulin resistance, insulin and adiponectin on kidney stones in the Japanese population. Int J Urol 18:131PubMedCrossRef
50.
Zurück zum Zitat Ferder L, Ferder MD, Inserra F (2010) The role of high-fructose corn syrup in metabolic syndrome and hypertension. Curr Hypertens Rep 12:105PubMedCrossRef Ferder L, Ferder MD, Inserra F (2010) The role of high-fructose corn syrup in metabolic syndrome and hypertension. Curr Hypertens Rep 12:105PubMedCrossRef
51.
Zurück zum Zitat Jalal DI, Smits G, Johnson RJ et al (2010) Increased fructose associates with elevated blood pressure. J Am Soc Nephrol 21:1543PubMedCrossRef Jalal DI, Smits G, Johnson RJ et al (2010) Increased fructose associates with elevated blood pressure. J Am Soc Nephrol 21:1543PubMedCrossRef
52.
Zurück zum Zitat Taylor EN, Curhan GC (2008) Fructose consumption and the risk of kidney stones. Kidney Int 73:207PubMedCrossRef Taylor EN, Curhan GC (2008) Fructose consumption and the risk of kidney stones. Kidney Int 73:207PubMedCrossRef
54.
Zurück zum Zitat Kok DJ, Khan SR (1994) Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 46:847PubMedCrossRef Kok DJ, Khan SR (1994) Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 46:847PubMedCrossRef
55.
56.
Zurück zum Zitat Cameron MA, Maalouf NM, Adams-Huet B et al (2006) Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol 17:1422PubMedCrossRef Cameron MA, Maalouf NM, Adams-Huet B et al (2006) Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol 17:1422PubMedCrossRef
57.
Zurück zum Zitat Strazzullo P, Mancini M (1994) Hypertension, calcium metabolism, and nephrolithiasis. Am J Med Sci 307(Suppl 1):S102PubMed Strazzullo P, Mancini M (1994) Hypertension, calcium metabolism, and nephrolithiasis. Am J Med Sci 307(Suppl 1):S102PubMed
58.
Zurück zum Zitat Timio F, Kerry SM, Anson KM et al (2003) Calcium urolithiasis, blood pressure and salt intake. Blood Press 12:122PubMedCrossRef Timio F, Kerry SM, Anson KM et al (2003) Calcium urolithiasis, blood pressure and salt intake. Blood Press 12:122PubMedCrossRef
59.
60.
Zurück zum Zitat Mente A, Honey RJ, McLaughlin JM et al (2006) High urinary calcium excretion and genetic susceptibility to hypertension and kidney stone disease. J Am Soc Nephrol 17:2567PubMedCrossRef Mente A, Honey RJ, McLaughlin JM et al (2006) High urinary calcium excretion and genetic susceptibility to hypertension and kidney stone disease. J Am Soc Nephrol 17:2567PubMedCrossRef
61.
Zurück zum Zitat Schleicher MM, Reis MC, Costa SS et al (2009) Patients with nephrolithiasis and blood hypertension have higher calciuria than those with isolated nephrolithiasis or hypertension? Minerva Urol Nefrol 61:9PubMed Schleicher MM, Reis MC, Costa SS et al (2009) Patients with nephrolithiasis and blood hypertension have higher calciuria than those with isolated nephrolithiasis or hypertension? Minerva Urol Nefrol 61:9PubMed
62.
Zurück zum Zitat Eisner BH, Porten SP, Bechis SK et al (2010) Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis. J Urol 183:576PubMedCrossRef Eisner BH, Porten SP, Bechis SK et al (2010) Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis. J Urol 183:576PubMedCrossRef
63.
Zurück zum Zitat Taylor EN, Mount DB, Forman JP et al (2006) Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors. Am J Kidney Dis 47:780PubMedCrossRef Taylor EN, Mount DB, Forman JP et al (2006) Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors. Am J Kidney Dis 47:780PubMedCrossRef
64.
Zurück zum Zitat Maalouf NM, Cameron MA, Moe OW et al (2010) Metabolic basis for low urine pH in type 2 diabetes. Clin J Am Soc Nephrol 5:1277PubMedCrossRef Maalouf NM, Cameron MA, Moe OW et al (2010) Metabolic basis for low urine pH in type 2 diabetes. Clin J Am Soc Nephrol 5:1277PubMedCrossRef
66.
Zurück zum Zitat Carpentier X, Bazin D, Jungers P et al (2010) The pathogenesis of Randall’s plaque: a papilla cartography of Ca compounds through an ex vivo investigation based on XANES spectroscopy. J Synchrotron Radiat 17:374PubMedCrossRef Carpentier X, Bazin D, Jungers P et al (2010) The pathogenesis of Randall’s plaque: a papilla cartography of Ca compounds through an ex vivo investigation based on XANES spectroscopy. J Synchrotron Radiat 17:374PubMedCrossRef
67.
Zurück zum Zitat Khan SR, Finlayson B, Hackett R (1984) Renal papillary changes in patient with calcium oxalate lithiasis. Urology 23:194PubMedCrossRef Khan SR, Finlayson B, Hackett R (1984) Renal papillary changes in patient with calcium oxalate lithiasis. Urology 23:194PubMedCrossRef
68.
Zurück zum Zitat Evan AP, Lingeman JE, Coe FL et al (2003) Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111:607PubMed Evan AP, Lingeman JE, Coe FL et al (2003) Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111:607PubMed
69.
Zurück zum Zitat Weller RO, Nester B, Cooke SAR (1971) Calcification in the human renal papilla: an electron microscope study. J Pathol 107:211CrossRef Weller RO, Nester B, Cooke SAR (1971) Calcification in the human renal papilla: an electron microscope study. J Pathol 107:211CrossRef
70.
Zurück zum Zitat Stoller ML, Meng MV, Abrahams HM et al (2004) The primary stone event: a new hypothesis involving a vascular etiology. J Urol 171:1920PubMedCrossRef Stoller ML, Meng MV, Abrahams HM et al (2004) The primary stone event: a new hypothesis involving a vascular etiology. J Urol 171:1920PubMedCrossRef
71.
Zurück zum Zitat Miller NL, Gillen DL, Williams JC Jr et al (2009) A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall’s plaque. BJU Int 103:966PubMedCrossRef Miller NL, Gillen DL, Williams JC Jr et al (2009) A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall’s plaque. BJU Int 103:966PubMedCrossRef
72.
Zurück zum Zitat Coe FL, Evan AP, Lingeman JE et al (2010) Plaque and deposits in nine human stone diseases. Urol Res 38:239PubMedCrossRef Coe FL, Evan AP, Lingeman JE et al (2010) Plaque and deposits in nine human stone diseases. Urol Res 38:239PubMedCrossRef
73.
Zurück zum Zitat Evan AP, Lingeman JE, Coe FL et al (2008) Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Semin Nephrol 28:111PubMedCrossRef Evan AP, Lingeman JE, Coe FL et al (2008) Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Semin Nephrol 28:111PubMedCrossRef
74.
Zurück zum Zitat Evan AP (2009) Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol 25:831PubMedCrossRef Evan AP (2009) Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol 25:831PubMedCrossRef
75.
Zurück zum Zitat Evan AP, Coe FL, Rittling SR et al (2005) Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int 68:145PubMedCrossRef Evan AP, Coe FL, Rittling SR et al (2005) Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int 68:145PubMedCrossRef
76.
Zurück zum Zitat Evan AP, Bledsoe S, Worcester EM et al (2007) Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients. Kidney Int 72:1503PubMedCrossRef Evan AP, Bledsoe S, Worcester EM et al (2007) Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients. Kidney Int 72:1503PubMedCrossRef
77.
Zurück zum Zitat Evan A, Lingeman J, Coe FL et al (2006) Randall’s plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int 69:1313PubMedCrossRef Evan A, Lingeman J, Coe FL et al (2006) Randall’s plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int 69:1313PubMedCrossRef
78.
Zurück zum Zitat Haggit RC, Pitcock JA (1971) Renal medullary calcification: a light and electron microscopic study. J Urol 106:342 Haggit RC, Pitcock JA (1971) Renal medullary calcification: a light and electron microscopic study. J Urol 106:342
79.
80.
Zurück zum Zitat Carpentier X, Bazin D, Combes C et al (2011) High Zn content of Randall’s plaque: a mu-X-ray fluorescence investigation. J Trace Elem Med Biol 25:160PubMedCrossRef Carpentier X, Bazin D, Combes C et al (2011) High Zn content of Randall’s plaque: a mu-X-ray fluorescence investigation. J Trace Elem Med Biol 25:160PubMedCrossRef
81.
Zurück zum Zitat Khan SR (2004) Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol 8:75PubMedCrossRef Khan SR (2004) Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol 8:75PubMedCrossRef
82.
Zurück zum Zitat Gower LB (2008) Biomimetic model systems for investigating the amorphous precursor pathway and its role in biomineralization. Chem Rev 108:4551PubMedCrossRef Gower LB (2008) Biomimetic model systems for investigating the amorphous precursor pathway and its role in biomineralization. Chem Rev 108:4551PubMedCrossRef
83.
Zurück zum Zitat Murshed M, McKee MD (2010) Molecular determinants of extracellular matrix mineralization in bone and blood vessels. Curr Opin Nephrol Hypertens 19:359PubMedCrossRef Murshed M, McKee MD (2010) Molecular determinants of extracellular matrix mineralization in bone and blood vessels. Curr Opin Nephrol Hypertens 19:359PubMedCrossRef
84.
Zurück zum Zitat Baggio B, Gambaro G, Ossi E et al (1983) Increased urinary excretion of renal enzymes in idiopathic calcium oxalate nephrolithiasis. J Urol 129:1161PubMed Baggio B, Gambaro G, Ossi E et al (1983) Increased urinary excretion of renal enzymes in idiopathic calcium oxalate nephrolithiasis. J Urol 129:1161PubMed
85.
Zurück zum Zitat Huang HS, Ma MC, Chen CF et al (2003) Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones. Urology 62:1123PubMedCrossRef Huang HS, Ma MC, Chen CF et al (2003) Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones. Urology 62:1123PubMedCrossRef
86.
Zurück zum Zitat Tungsanga K, Sriboonlue P, Futrakul P et al (2005) Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment. Urol Res 33:65PubMedCrossRef Tungsanga K, Sriboonlue P, Futrakul P et al (2005) Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment. Urol Res 33:65PubMedCrossRef
87.
Zurück zum Zitat Boonla C, Wunsuwan R, Tungsanga K et al (2007) Urinary 8-hydroxydeoxyguanosine is elevated in patients with nephrolithiasis. Urol Res 35:185PubMedCrossRef Boonla C, Wunsuwan R, Tungsanga K et al (2007) Urinary 8-hydroxydeoxyguanosine is elevated in patients with nephrolithiasis. Urol Res 35:185PubMedCrossRef
88.
Zurück zum Zitat Tsao KC, Wu TL, Chang PY et al (2007) Multiple risk markers for atherogenesis associated with chronic inflammation are detectable in patients with renal stones. J Clin Lab Anal 21:426PubMedCrossRef Tsao KC, Wu TL, Chang PY et al (2007) Multiple risk markers for atherogenesis associated with chronic inflammation are detectable in patients with renal stones. J Clin Lab Anal 21:426PubMedCrossRef
89.
Zurück zum Zitat Mushtaq S, Siddiqui AA, Naqvi ZA et al (2007) Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones. Clin Chim Acta 384:41PubMedCrossRef Mushtaq S, Siddiqui AA, Naqvi ZA et al (2007) Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones. Clin Chim Acta 384:41PubMedCrossRef
90.
Zurück zum Zitat Taylor EN, Fung TT, Curhan GC (2009) DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol 20:2253PubMedCrossRef Taylor EN, Fung TT, Curhan GC (2009) DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol 20:2253PubMedCrossRef
91.
Zurück zum Zitat Evan AP, Coe FL, Lingeman JE et al (2006) Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int 69:2227PubMedCrossRef Evan AP, Coe FL, Lingeman JE et al (2006) Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int 69:2227PubMedCrossRef
92.
Zurück zum Zitat Evan AP, Lingeman J, Coe F et al (2007) Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int 71:795PubMedCrossRef Evan AP, Lingeman J, Coe F et al (2007) Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int 71:795PubMedCrossRef
93.
Zurück zum Zitat Evan AP, Lingeman JE, Coe FL et al (2005) Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int 67:576PubMedCrossRef Evan AP, Lingeman JE, Coe FL et al (2005) Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int 67:576PubMedCrossRef
94.
Zurück zum Zitat Evan AP, Lingeman JE, Worcester EM et al (2010) Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease. Kidney Int 78:310PubMedCrossRef Evan AP, Lingeman JE, Worcester EM et al (2010) Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease. Kidney Int 78:310PubMedCrossRef
95.
Zurück zum Zitat Evan AP, Coe FL, Gillen D et al (2008) Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec (Hoboken) 291:325CrossRef Evan AP, Coe FL, Gillen D et al (2008) Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec (Hoboken) 291:325CrossRef
96.
Zurück zum Zitat Evan AE, Lingeman JE, Coe FL et al (2008) Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. Kidney Int 74:223PubMedCrossRef Evan AE, Lingeman JE, Coe FL et al (2008) Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. Kidney Int 74:223PubMedCrossRef
97.
Zurück zum Zitat Escobar C, Byer KJ, Khaskheli H et al (2008) Apatite induced renal epithelial injury: insight into the pathogenesis of kidney stones. J Urol 180:379PubMedCrossRef Escobar C, Byer KJ, Khaskheli H et al (2008) Apatite induced renal epithelial injury: insight into the pathogenesis of kidney stones. J Urol 180:379PubMedCrossRef
98.
Zurück zum Zitat Aihara K, Byer KJ, Khan SR (2003) Calcium phosphate-induced renal epithelial injury and stone formation: involvement of reactive oxygen species. Kidney Int 64:1283PubMedCrossRef Aihara K, Byer KJ, Khan SR (2003) Calcium phosphate-induced renal epithelial injury and stone formation: involvement of reactive oxygen species. Kidney Int 64:1283PubMedCrossRef
99.
Zurück zum Zitat Umekawa T, Byer K, Uemura H et al (2005) Diphenyleneiodium (DPI) reduces oxalate ion- and calcium oxalate monohydrate and brushite crystal-induced upregulation of MCP-1 in NRK 52E cells. Nephrol Dial Transplant 20:870PubMedCrossRef Umekawa T, Byer K, Uemura H et al (2005) Diphenyleneiodium (DPI) reduces oxalate ion- and calcium oxalate monohydrate and brushite crystal-induced upregulation of MCP-1 in NRK 52E cells. Nephrol Dial Transplant 20:870PubMedCrossRef
100.
Zurück zum Zitat Umekawa T, Chegini N, Khan SR (2003) Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Nephrol Dial Transplant 18:664PubMedCrossRef Umekawa T, Chegini N, Khan SR (2003) Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Nephrol Dial Transplant 18:664PubMedCrossRef
101.
Zurück zum Zitat Giachelli CM (2005) Inducers and inhibitors of biomineralization: lessons from pathological calcification. Orthod Craniofac Res 8:229PubMedCrossRef Giachelli CM (2005) Inducers and inhibitors of biomineralization: lessons from pathological calcification. Orthod Craniofac Res 8:229PubMedCrossRef
102.
Zurück zum Zitat Thamilselvan S, Hackett RL, Khan SR (1997) Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. J Urol 157:1059PubMedCrossRef Thamilselvan S, Hackett RL, Khan SR (1997) Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. J Urol 157:1059PubMedCrossRef
103.
Zurück zum Zitat Thamilselvan S, Hackett RL, Khan SR (1999) Cells of proximal and distal tubular origin respond differently to challenges of oxalate and calcium oxalate crystals. J Am Soc Nephrol 10(Suppl 14):S452PubMed Thamilselvan S, Hackett RL, Khan SR (1999) Cells of proximal and distal tubular origin respond differently to challenges of oxalate and calcium oxalate crystals. J Am Soc Nephrol 10(Suppl 14):S452PubMed
104.
Zurück zum Zitat Khan SR (2005) Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res 33:349PubMedCrossRef Khan SR (2005) Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res 33:349PubMedCrossRef
105.
Zurück zum Zitat Khan SR, Glenton PA, Byer KJ (2006) Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-l-proline. Kidney Int 70:914PubMedCrossRef Khan SR, Glenton PA, Byer KJ (2006) Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-l-proline. Kidney Int 70:914PubMedCrossRef
106.
Zurück zum Zitat Khan SR (1995) Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development. Urol Res 23:71PubMedCrossRef Khan SR (1995) Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development. Urol Res 23:71PubMedCrossRef
107.
Zurück zum Zitat Sumitra K, Pragasam V, Sakthivel R et al (2005) Beneficial effect of vitamin E supplementation on the biochemical and kinetic properties of Tamm–Horsfall glycoprotein in hypertensive and hyperoxaluric patients. Nephrol Dial Transplant 20:1407PubMedCrossRef Sumitra K, Pragasam V, Sakthivel R et al (2005) Beneficial effect of vitamin E supplementation on the biochemical and kinetic properties of Tamm–Horsfall glycoprotein in hypertensive and hyperoxaluric patients. Nephrol Dial Transplant 20:1407PubMedCrossRef
108.
Zurück zum Zitat Huang HS, Chen J, Chen CF et al (2006) Vitamin E attenuates crystal formation in rat kidneys: roles of renal tubular cell death and crystallization inhibitors. Kidney Int 70:699PubMedCrossRef Huang HS, Chen J, Chen CF et al (2006) Vitamin E attenuates crystal formation in rat kidneys: roles of renal tubular cell death and crystallization inhibitors. Kidney Int 70:699PubMedCrossRef
109.
Zurück zum Zitat Thamilselvan S, Byer KJ, Hackett RL et al (2000) Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-associated injury to LLC-PK1 and MDCK cells. J Urol 164:224PubMedCrossRef Thamilselvan S, Byer KJ, Hackett RL et al (2000) Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-associated injury to LLC-PK1 and MDCK cells. J Urol 164:224PubMedCrossRef
110.
Zurück zum Zitat Thamilselvan S, Khan SR, Menon M (2003) Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 31:3PubMed Thamilselvan S, Khan SR, Menon M (2003) Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 31:3PubMed
111.
Zurück zum Zitat Khand FD, Gordge MP, Robertson WG et al (2002) Mitochondrial superoxide production during oxalate-mediated oxidative stress in renal epithelial cells. Free Radic Biol Med 32:1339PubMedCrossRef Khand FD, Gordge MP, Robertson WG et al (2002) Mitochondrial superoxide production during oxalate-mediated oxidative stress in renal epithelial cells. Free Radic Biol Med 32:1339PubMedCrossRef
112.
Zurück zum Zitat Meimaridou E, Jacobson J, Seddon AM et al (2005) Crystal and microparticle effects on MDCK cell superoxide production: oxalate-specific mitochondrial membrane potential changes. Free Radic Biol Med 38:1553PubMedCrossRef Meimaridou E, Jacobson J, Seddon AM et al (2005) Crystal and microparticle effects on MDCK cell superoxide production: oxalate-specific mitochondrial membrane potential changes. Free Radic Biol Med 38:1553PubMedCrossRef
113.
Zurück zum Zitat Cao LC, Honeyman TW, Cooney R et al (2004) Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity. Kidney Int 66:1890PubMedCrossRef Cao LC, Honeyman TW, Cooney R et al (2004) Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity. Kidney Int 66:1890PubMedCrossRef
114.
Zurück zum Zitat Khan SR, Khan A, Byer KJ (2011) Temporal changes in the expression of mRNA of NADPH oxidase subunits in renal epithelial cells exposed to oxalate or calcium oxalate crystals. Nephrol Dial Transplant 26:1778PubMedCrossRef Khan SR, Khan A, Byer KJ (2011) Temporal changes in the expression of mRNA of NADPH oxidase subunits in renal epithelial cells exposed to oxalate or calcium oxalate crystals. Nephrol Dial Transplant 26:1778PubMedCrossRef
115.
Zurück zum Zitat Li N, Yi FX, Spurrier JL et al (2002) Production of superoxide through NADH oxidase in thick ascending limb of Henle’s loop in rat kidney. Am J Physiol Renal Physiol 282:F1111PubMed Li N, Yi FX, Spurrier JL et al (2002) Production of superoxide through NADH oxidase in thick ascending limb of Henle’s loop in rat kidney. Am J Physiol Renal Physiol 282:F1111PubMed
116.
Zurück zum Zitat Geiszt M, Kopp JB, Varnai P et al (2000) Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci USA 97:8010PubMedCrossRef Geiszt M, Kopp JB, Varnai P et al (2000) Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci USA 97:8010PubMedCrossRef
117.
Zurück zum Zitat Hanna IR, Taniyama Y, Szocs K et al (2002) NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal 4:899PubMedCrossRef Hanna IR, Taniyama Y, Szocs K et al (2002) NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal 4:899PubMedCrossRef
118.
Zurück zum Zitat Wilcox CS, Welch WJ (2001) Oxidative stress: cause or consequence of hypertension. Exp Biol Med (Maywood) 226:619 Wilcox CS, Welch WJ (2001) Oxidative stress: cause or consequence of hypertension. Exp Biol Med (Maywood) 226:619
119.
Zurück zum Zitat Shiose A, Kuroda J, Tsuruya K et al (2001) A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem 276:1417PubMedCrossRef Shiose A, Kuroda J, Tsuruya K et al (2001) A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem 276:1417PubMedCrossRef
120.
Zurück zum Zitat Thamilselvan V, Menon M, Thamilselvan S (2009) Oxalate-induced activation of PKC-alpha and -delta regulates NADPH oxidase-mediated oxidative injury in renal tubular epithelial cells. Am J Physiol Renal Physiol 297:F1399PubMedCrossRef Thamilselvan V, Menon M, Thamilselvan S (2009) Oxalate-induced activation of PKC-alpha and -delta regulates NADPH oxidase-mediated oxidative injury in renal tubular epithelial cells. Am J Physiol Renal Physiol 297:F1399PubMedCrossRef
121.
Zurück zum Zitat Thamilselvan V, Menon M, Thamilselvan S (2011) Selective Rac1 inhibition protects renal tubular epithelial cells from oxalate-induced NADPH oxidase-mediated oxidative cell injury. Urol Res [Epub ahead of print] Thamilselvan V, Menon M, Thamilselvan S (2011) Selective Rac1 inhibition protects renal tubular epithelial cells from oxalate-induced NADPH oxidase-mediated oxidative cell injury. Urol Res [Epub ahead of print]
122.
Zurück zum Zitat Zuo J, Khan A, Glenton PA et al (2011) Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-l-proline-induced hyperoxaluria in the male Sprague-Dawley rats. Nephrol Dial Transplant 26:1785PubMedCrossRef Zuo J, Khan A, Glenton PA et al (2011) Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-l-proline-induced hyperoxaluria in the male Sprague-Dawley rats. Nephrol Dial Transplant 26:1785PubMedCrossRef
123.
Zurück zum Zitat Wassmann S, Laufs U, Muller K et al (2002) Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol 22:300PubMedCrossRef Wassmann S, Laufs U, Muller K et al (2002) Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol 22:300PubMedCrossRef
124.
Zurück zum Zitat Tsujihata M, Momohara C, Yoshioka I et al (2008) Atorvastatin inhibits renal crystal retention in a rat stone forming model. J Urol 180:2212PubMedCrossRef Tsujihata M, Momohara C, Yoshioka I et al (2008) Atorvastatin inhibits renal crystal retention in a rat stone forming model. J Urol 180:2212PubMedCrossRef
125.
Zurück zum Zitat Toblli JE, Ferder L, Stella I et al (2001) Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria. J Urol 166:275PubMedCrossRef Toblli JE, Ferder L, Stella I et al (2001) Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria. J Urol 166:275PubMedCrossRef
126.
Zurück zum Zitat Toblli JE, Ferder L, Stella I et al (2002) Effects of angiotensin II subtype 1 receptor blockade by losartan on tubulointerstitial lesions caused by hyperoxaluria. J Urol 168:1550PubMedCrossRef Toblli JE, Ferder L, Stella I et al (2002) Effects of angiotensin II subtype 1 receptor blockade by losartan on tubulointerstitial lesions caused by hyperoxaluria. J Urol 168:1550PubMedCrossRef
127.
Zurück zum Zitat Umekawa T, Hatanaka Y, Kurita T et al (2004) Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in rat kidneys. J Am Soc Nephrol 15:635PubMedCrossRef Umekawa T, Hatanaka Y, Kurita T et al (2004) Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in rat kidneys. J Am Soc Nephrol 15:635PubMedCrossRef
128.
Zurück zum Zitat Khan SR, Shevock PN, Hackett RL (1992) Acute hyperoxaluria, renal injury and calcium oxalate urolithiasis. J Urol 147:226PubMed Khan SR, Shevock PN, Hackett RL (1992) Acute hyperoxaluria, renal injury and calcium oxalate urolithiasis. J Urol 147:226PubMed
129.
Zurück zum Zitat de Bruijn WC, Boeve ER, van Run PR et al (1995) Etiology of calcium oxalate nephrolithiasis in rats. I. Can this be a model for human stone formation? Scanning Microsc 9:103PubMed de Bruijn WC, Boeve ER, van Run PR et al (1995) Etiology of calcium oxalate nephrolithiasis in rats. I. Can this be a model for human stone formation? Scanning Microsc 9:103PubMed
130.
Zurück zum Zitat de Water R, Noordermeer C, van der Kwast TH et al (1999) Calcium oxalate nephrolithiasis: effect of renal crystal deposition on the cellular composition of the renal interstitium. Am J Kidney Dis 33:761PubMedCrossRef de Water R, Noordermeer C, van der Kwast TH et al (1999) Calcium oxalate nephrolithiasis: effect of renal crystal deposition on the cellular composition of the renal interstitium. Am J Kidney Dis 33:761PubMedCrossRef
131.
Zurück zum Zitat McKee MD, Nanci A, Khan SR (1995) Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi. J Bone Miner Res 10:1913PubMedCrossRef McKee MD, Nanci A, Khan SR (1995) Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi. J Bone Miner Res 10:1913PubMedCrossRef
132.
Zurück zum Zitat Umekawa T, Tsuji H, Uemura H et al (2009) Superoxide from NADPH oxidase as second messenger for the expression of osteopontin and monocyte chemoattractant protein-1 in renal epithelial cells exposed to calcium oxalate crystals. BJU Int 104:115PubMedCrossRef Umekawa T, Tsuji H, Uemura H et al (2009) Superoxide from NADPH oxidase as second messenger for the expression of osteopontin and monocyte chemoattractant protein-1 in renal epithelial cells exposed to calcium oxalate crystals. BJU Int 104:115PubMedCrossRef
133.
Zurück zum Zitat Rashed T, Menon M, Thamilselvan S (2004) Molecular mechanism of oxalate-induced free radical production and glutathione redox imbalance in renal epithelial cells: effect of antioxidants. Am J Nephrol 24:557PubMedCrossRef Rashed T, Menon M, Thamilselvan S (2004) Molecular mechanism of oxalate-induced free radical production and glutathione redox imbalance in renal epithelial cells: effect of antioxidants. Am J Nephrol 24:557PubMedCrossRef
134.
Zurück zum Zitat Koul HK, Menon M, Chaturvedi LS et al (2002) COM crystals activate the p38 mitogen-activated protein kinase signal transduction pathway in renal epithelial cells. J Biol Chem 277:36845PubMedCrossRef Koul HK, Menon M, Chaturvedi LS et al (2002) COM crystals activate the p38 mitogen-activated protein kinase signal transduction pathway in renal epithelial cells. J Biol Chem 277:36845PubMedCrossRef
135.
Zurück zum Zitat Chaturvedi LS, Koul S, Sekhon A et al (2002) Oxalate selectively activates p38 mitogen-activated protein kinase and c-Jun N-terminal kinase signal transduction pathways in renal epithelial cells. J Biol Chem 277:13321PubMedCrossRef Chaturvedi LS, Koul S, Sekhon A et al (2002) Oxalate selectively activates p38 mitogen-activated protein kinase and c-Jun N-terminal kinase signal transduction pathways in renal epithelial cells. J Biol Chem 277:13321PubMedCrossRef
136.
Zurück zum Zitat Toblli JE, Cao G, Casas G et al (2005) NF-kappaB and chemokine-cytokine expression in renal tubulointerstitium in experimental hyperoxaluria. Role of the renin–angiotensin system. Urol Res 33:358PubMedCrossRef Toblli JE, Cao G, Casas G et al (2005) NF-kappaB and chemokine-cytokine expression in renal tubulointerstitium in experimental hyperoxaluria. Role of the renin–angiotensin system. Urol Res 33:358PubMedCrossRef
137.
Zurück zum Zitat Jonassen JA, Cao LC, Honeyman T et al (2003) Mechanisms mediating oxalate-induced alterations in renal cell functions. Crit Rev Eukaryot Gene Expr 13:55PubMedCrossRef Jonassen JA, Cao LC, Honeyman T et al (2003) Mechanisms mediating oxalate-induced alterations in renal cell functions. Crit Rev Eukaryot Gene Expr 13:55PubMedCrossRef
138.
Zurück zum Zitat Umekawa T, Chegini N, Khan SR (2002) Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells. Kidney Int 61:105PubMedCrossRef Umekawa T, Chegini N, Khan SR (2002) Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells. Kidney Int 61:105PubMedCrossRef
139.
Zurück zum Zitat Umekawa T, Iguchi M, Uemura H et al (2006) Oxalate ions and calcium oxalate crystal-induced up-regulation of osteopontin and monocyte chemoattractant protein-1 in renal fibroblasts. BJU Int 98:656PubMedCrossRef Umekawa T, Iguchi M, Uemura H et al (2006) Oxalate ions and calcium oxalate crystal-induced up-regulation of osteopontin and monocyte chemoattractant protein-1 in renal fibroblasts. BJU Int 98:656PubMedCrossRef
140.
Zurück zum Zitat Iida S, Peck AB, Byer KJ et al (1999) Expression of bikunin mRNA in renal epithelial cells after oxalate exposure. J Urol 162:1480PubMedCrossRef Iida S, Peck AB, Byer KJ et al (1999) Expression of bikunin mRNA in renal epithelial cells after oxalate exposure. J Urol 162:1480PubMedCrossRef
141.
Zurück zum Zitat Iida S, Peck AB, Johnson-Tardieu J et al (1999) Temporal changes in mRNA expression for bikunin in the kidneys of rats during calcium oxalate nephrolithiasis. J Am Soc Nephrol 10:986PubMed Iida S, Peck AB, Johnson-Tardieu J et al (1999) Temporal changes in mRNA expression for bikunin in the kidneys of rats during calcium oxalate nephrolithiasis. J Am Soc Nephrol 10:986PubMed
142.
Zurück zum Zitat Grewal JS, Tsai JY, Khan SR (2005) Oxalate-inducible AMBP gene and its regulatory mechanism in renal tubular epithelial cells. Biochem J 387:609PubMedCrossRef Grewal JS, Tsai JY, Khan SR (2005) Oxalate-inducible AMBP gene and its regulatory mechanism in renal tubular epithelial cells. Biochem J 387:609PubMedCrossRef
143.
Zurück zum Zitat Moriyama MT, Glenton PA, Khan SR (2001) Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats. J Urol 165:1687PubMedCrossRef Moriyama MT, Glenton PA, Khan SR (2001) Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats. J Urol 165:1687PubMedCrossRef
144.
Zurück zum Zitat Suzuki K, Tanaka T, Miyazawa K et al (1999) Gene expression of prothrombin in human and rat kidneys: basic and clinical approach. J Am Soc Nephrol 10(Suppl 14):S408PubMed Suzuki K, Tanaka T, Miyazawa K et al (1999) Gene expression of prothrombin in human and rat kidneys: basic and clinical approach. J Am Soc Nephrol 10(Suppl 14):S408PubMed
145.
Zurück zum Zitat Lieske JC, Spargo BH, Toback FG (1992) Endocytosis of calcium oxalate crystals and proliferation of renal tubular epithelial cells in a patient with type 1 primary hyperoxaluria. J Urol 148:1517PubMed Lieske JC, Spargo BH, Toback FG (1992) Endocytosis of calcium oxalate crystals and proliferation of renal tubular epithelial cells in a patient with type 1 primary hyperoxaluria. J Urol 148:1517PubMed
146.
Zurück zum Zitat Mandell I, Krauss E, Millan JC (1980) Oxalate-induced acute renal failure in Crohn’s disease. Am J Med 69:628PubMedCrossRef Mandell I, Krauss E, Millan JC (1980) Oxalate-induced acute renal failure in Crohn’s disease. Am J Med 69:628PubMedCrossRef
147.
Zurück zum Zitat Wharton R, D’Agati V, Magun AM et al (1990) Acute deterioration of renal function associated with enteric hyperoxaluria. Clin Nephrol 34:116PubMed Wharton R, D’Agati V, Magun AM et al (1990) Acute deterioration of renal function associated with enteric hyperoxaluria. Clin Nephrol 34:116PubMed
148.
Zurück zum Zitat Whitworth JA (2003) 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21:1983PubMedCrossRef Whitworth JA (2003) 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21:1983PubMedCrossRef
149.
Zurück zum Zitat Moritz AR, Oldt MR (1937) Arteriolar sclerosis in hypertensive and non-hypertensive individuals. Am J Pathol 13:679PubMed Moritz AR, Oldt MR (1937) Arteriolar sclerosis in hypertensive and non-hypertensive individuals. Am J Pathol 13:679PubMed
150.
Zurück zum Zitat Kimmelstiel P, Wilson C (1936) Benign and malignant hypertension and nephrosclerosis: a clinical and pathological study. Am J Pathol 12:45PubMed Kimmelstiel P, Wilson C (1936) Benign and malignant hypertension and nephrosclerosis: a clinical and pathological study. Am J Pathol 12:45PubMed
151.
Zurück zum Zitat Johnson RJ, Feig DI, Nakagawa T et al (2008) Pathogenesis of essential hypertension: historical paradigms and modern insights. J Hypertens 26:381PubMedCrossRef Johnson RJ, Feig DI, Nakagawa T et al (2008) Pathogenesis of essential hypertension: historical paradigms and modern insights. J Hypertens 26:381PubMedCrossRef
152.
Zurück zum Zitat Montecucco F, Pende A, Quercioli A et al (2010) Inflammation in the pathophysiology of essential hypertension. J Nephrol 24:23CrossRef Montecucco F, Pende A, Quercioli A et al (2010) Inflammation in the pathophysiology of essential hypertension. J Nephrol 24:23CrossRef
153.
Zurück zum Zitat Rodriguez-Iturbe B, Franco M, Tapia E et al (2011) Renal inflammation, autoimmunity and salt-sensitive hypertension. Clin Exp Pharmacol Physiol [Epub ahead of print] Rodriguez-Iturbe B, Franco M, Tapia E et al (2011) Renal inflammation, autoimmunity and salt-sensitive hypertension. Clin Exp Pharmacol Physiol [Epub ahead of print]
154.
Zurück zum Zitat Rodriguez-Iturbe B, Vaziri ND, Johnson RJ (2008) Inflammation, angiotensin II, and hypertension. Hypertension 52:e135 (author reply e136) Rodriguez-Iturbe B, Vaziri ND, Johnson RJ (2008) Inflammation, angiotensin II, and hypertension. Hypertension 52:e135 (author reply e136)
155.
Zurück zum Zitat Rodriguez-Iturbe B, Vaziri ND, Herrera-Acosta J et al (2004) Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol 286:F606PubMedCrossRef Rodriguez-Iturbe B, Vaziri ND, Herrera-Acosta J et al (2004) Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol 286:F606PubMedCrossRef
156.
Zurück zum Zitat Stefanadi E, Tousoulis D, Androulakis ES et al (2010) Inflammatory markers in essential hypertension: potential clinical implications. Curr Vasc Pharmacol 8:509PubMedCrossRef Stefanadi E, Tousoulis D, Androulakis ES et al (2010) Inflammatory markers in essential hypertension: potential clinical implications. Curr Vasc Pharmacol 8:509PubMedCrossRef
157.
Zurück zum Zitat Briones AM, Touyz RM (2010) Oxidative stress and hypertension: current concepts. Curr Hypertens Rep 12:135PubMedCrossRef Briones AM, Touyz RM (2010) Oxidative stress and hypertension: current concepts. Curr Hypertens Rep 12:135PubMedCrossRef
158.
Zurück zum Zitat Nistala R, Whaley-Connell A, Sowers JR (2008) Redox control of renal function and hypertension. Antioxid Redox Signal 10:2047PubMedCrossRef Nistala R, Whaley-Connell A, Sowers JR (2008) Redox control of renal function and hypertension. Antioxid Redox Signal 10:2047PubMedCrossRef
159.
Zurück zum Zitat Bautista LE, Lopez-Jaramillo P, Vera LM et al (2001) Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens 19:857PubMedCrossRef Bautista LE, Lopez-Jaramillo P, Vera LM et al (2001) Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens 19:857PubMedCrossRef
160.
Zurück zum Zitat Chrysohoou C, Panagiotakos DB, Pitsavos C et al (2004) Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study. J Am Coll Cardiol 44:152PubMedCrossRef Chrysohoou C, Panagiotakos DB, Pitsavos C et al (2004) Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study. J Am Coll Cardiol 44:152PubMedCrossRef
161.
Zurück zum Zitat Sesso HD, Buring JE, Rifai N et al (2003) C-reactive protein and the risk of developing hypertension. JAMA 290:2945PubMedCrossRef Sesso HD, Buring JE, Rifai N et al (2003) C-reactive protein and the risk of developing hypertension. JAMA 290:2945PubMedCrossRef
162.
Zurück zum Zitat Kurata M, Okura T, Watanabe S et al (2006) Osteopontin and carotid atherosclerosis in patients with essential hypertension. Clin Sci (Lond) 111:319CrossRef Kurata M, Okura T, Watanabe S et al (2006) Osteopontin and carotid atherosclerosis in patients with essential hypertension. Clin Sci (Lond) 111:319CrossRef
163.
Zurück zum Zitat Stumpf C, John S, Jukic J et al (2005) Enhanced levels of platelet P-selectin and circulating cytokines in young patients with mild arterial hypertension. J Hypertens 23:995PubMedCrossRef Stumpf C, John S, Jukic J et al (2005) Enhanced levels of platelet P-selectin and circulating cytokines in young patients with mild arterial hypertension. J Hypertens 23:995PubMedCrossRef
164.
Zurück zum Zitat Wilcox CS (2002) Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep 4:160PubMedCrossRef Wilcox CS (2002) Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep 4:160PubMedCrossRef
165.
Zurück zum Zitat O’Connor PM, Cowley AW Jr (2010) Modulation of pressure-natriuresis by renal medullary reactive oxygen species and nitric oxide. Curr Hypertens Rep 12:86PubMedCrossRef O’Connor PM, Cowley AW Jr (2010) Modulation of pressure-natriuresis by renal medullary reactive oxygen species and nitric oxide. Curr Hypertens Rep 12:86PubMedCrossRef
166.
Zurück zum Zitat Ignarro LJ, Napoli C, Loscalzo J (2002) Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ Res 90:21PubMedCrossRef Ignarro LJ, Napoli C, Loscalzo J (2002) Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ Res 90:21PubMedCrossRef
167.
Zurück zum Zitat Armas-Padilla MC, Armas-Hernandez MJ, Sosa-Canache B et al (2007) Nitric oxide and malondialdehyde in human hypertension. Am J Ther 14:172PubMedCrossRef Armas-Padilla MC, Armas-Hernandez MJ, Sosa-Canache B et al (2007) Nitric oxide and malondialdehyde in human hypertension. Am J Ther 14:172PubMedCrossRef
168.
Zurück zum Zitat Rodriguez-Iturbe B, Romero F, Johnson RJ (2007) Pathophysiological mechanisms of salt-dependent hypertension. Am J Kidney Dis 50:655PubMedCrossRef Rodriguez-Iturbe B, Romero F, Johnson RJ (2007) Pathophysiological mechanisms of salt-dependent hypertension. Am J Kidney Dis 50:655PubMedCrossRef
169.
Zurück zum Zitat Chabrashvili T, Tojo A, Onozato ML et al (2002) Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39:269PubMedCrossRef Chabrashvili T, Tojo A, Onozato ML et al (2002) Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39:269PubMedCrossRef
170.
Zurück zum Zitat Schnackenberg CG, Welch WJ, Wilcox CS (1998) Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 32:59PubMed Schnackenberg CG, Welch WJ, Wilcox CS (1998) Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 32:59PubMed
171.
Zurück zum Zitat Zalba G, Beaumont FJ, San Jose G et al (2000) Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 35:1055PubMed Zalba G, Beaumont FJ, San Jose G et al (2000) Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 35:1055PubMed
172.
Zurück zum Zitat Grote K, Ortmann M, Salguero G et al (2006) Critical role for p47phox in renin–angiotensin system activation and blood pressure regulation. Cardiovasc Res 71:596PubMedCrossRef Grote K, Ortmann M, Salguero G et al (2006) Critical role for p47phox in renin–angiotensin system activation and blood pressure regulation. Cardiovasc Res 71:596PubMedCrossRef
173.
Zurück zum Zitat Landmesser U, Cai H, Dikalov S et al (2002) Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 40:511PubMedCrossRef Landmesser U, Cai H, Dikalov S et al (2002) Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 40:511PubMedCrossRef
174.
Zurück zum Zitat Zhou MS, Hernandez Schulman I, Pagano PJ et al (2006) Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure. Hypertension 47:81PubMedCrossRef Zhou MS, Hernandez Schulman I, Pagano PJ et al (2006) Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure. Hypertension 47:81PubMedCrossRef
175.
Zurück zum Zitat Tian N, Moore RS, Phillips WE et al (2008) NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol 295:R1858PubMedCrossRef Tian N, Moore RS, Phillips WE et al (2008) NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol 295:R1858PubMedCrossRef
176.
Zurück zum Zitat Taylor NE, Glocka P, Liang M et al (2006) NADPH oxidase in the renal medulla causes oxidative stress and contributes to salt-sensitive hypertension in Dahl S rats. Hypertension 47:692PubMedCrossRef Taylor NE, Glocka P, Liang M et al (2006) NADPH oxidase in the renal medulla causes oxidative stress and contributes to salt-sensitive hypertension in Dahl S rats. Hypertension 47:692PubMedCrossRef
177.
Zurück zum Zitat Kanwar YS, Sun L, Xie P et al (2011) A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol 6:395PubMedCrossRef Kanwar YS, Sun L, Xie P et al (2011) A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol 6:395PubMedCrossRef
178.
Zurück zum Zitat Navarro-Gonzalez JF, Mora-Fernandez C, Muros de Fuentes M et al (2011) Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol 7:327PubMedCrossRef Navarro-Gonzalez JF, Mora-Fernandez C, Muros de Fuentes M et al (2011) Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol 7:327PubMedCrossRef
179.
Zurück zum Zitat Steckelings UM, Rompe F, Kaschina E et al (2009) The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets. Fundam Clin Pharmacol 23:693PubMedCrossRef Steckelings UM, Rompe F, Kaschina E et al (2009) The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets. Fundam Clin Pharmacol 23:693PubMedCrossRef
180.
Zurück zum Zitat Matheson A, Willcox MD, Flanagan J et al (2010) Urinary biomarkers involved in type 2 diabetes: a review. Diabetes Metab Res Rev 26:150PubMedCrossRef Matheson A, Willcox MD, Flanagan J et al (2010) Urinary biomarkers involved in type 2 diabetes: a review. Diabetes Metab Res Rev 26:150PubMedCrossRef
181.
Zurück zum Zitat Okonogi H, Nishimura M, Utsunomiya Y et al (2001) Urinary type IV collagen excretion reflects renal morphological alterations and type IV collagen expression in patients with type 2 diabetes mellitus. Clin Nephrol 55:357PubMed Okonogi H, Nishimura M, Utsunomiya Y et al (2001) Urinary type IV collagen excretion reflects renal morphological alterations and type IV collagen expression in patients with type 2 diabetes mellitus. Clin Nephrol 55:357PubMed
182.
183.
Zurück zum Zitat Kakehi T, Yabe-Nishimura C (2008) NOX enzymes and diabetic complications. Semin Immunopathol 30:301PubMedCrossRef Kakehi T, Yabe-Nishimura C (2008) NOX enzymes and diabetic complications. Semin Immunopathol 30:301PubMedCrossRef
184.
Zurück zum Zitat Chung SS, Ho EC, Lam KS et al (2003) Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol 14:S233PubMedCrossRef Chung SS, Ho EC, Lam KS et al (2003) Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol 14:S233PubMedCrossRef
185.
Zurück zum Zitat Asaba K, Tojo A, Onozato ML et al (2005) Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int 67:1890PubMedCrossRef Asaba K, Tojo A, Onozato ML et al (2005) Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int 67:1890PubMedCrossRef
186.
Zurück zum Zitat Etoh T, Inoguchi T, Kakimoto M et al (2003) Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibility by interventive insulin treatment. Diabetologia 46:1428PubMedCrossRef Etoh T, Inoguchi T, Kakimoto M et al (2003) Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibility by interventive insulin treatment. Diabetologia 46:1428PubMedCrossRef
187.
Zurück zum Zitat Manea A (2010) NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology. Cell Tissue Res 342:325PubMedCrossRef Manea A (2010) NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology. Cell Tissue Res 342:325PubMedCrossRef
188.
Zurück zum Zitat Brown BG, Zhao XQ, Chait A et al (2001) Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345:1583PubMedCrossRef Brown BG, Zhao XQ, Chait A et al (2001) Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345:1583PubMedCrossRef
189.
Zurück zum Zitat Touyz RM (2003) Reactive oxygen species in vascular biology: role in arterial hypertension. Expert Rev Cardiovasc Ther 1:91PubMedCrossRef Touyz RM (2003) Reactive oxygen species in vascular biology: role in arterial hypertension. Expert Rev Cardiovasc Ther 1:91PubMedCrossRef
190.
Zurück zum Zitat Manea A, Manea SA, Gafencu AV et al (2007) Regulation of NADPH oxidase subunit p22(phox) by NF-κB in human aortic smooth muscle cells. Arch Physiol Biochem 113:163PubMedCrossRef Manea A, Manea SA, Gafencu AV et al (2007) Regulation of NADPH oxidase subunit p22(phox) by NF-κB in human aortic smooth muscle cells. Arch Physiol Biochem 113:163PubMedCrossRef
191.
Zurück zum Zitat Stefanadi E, Tousoulis D, Papageorgiou N et al (2010) Inflammatory biomarkers predicting events in atherosclerosis. Curr Med Chem 17:1690PubMedCrossRef Stefanadi E, Tousoulis D, Papageorgiou N et al (2010) Inflammatory biomarkers predicting events in atherosclerosis. Curr Med Chem 17:1690PubMedCrossRef
192.
Zurück zum Zitat De Rosa S, Cirillo P, Paglia A et al (2010) Reactive oxygen species and antioxidants in the pathophysiology of cardiovascular disease: does the actual knowledge justify a clinical approach? Curr Vasc Pharmacol 8:259PubMedCrossRef De Rosa S, Cirillo P, Paglia A et al (2010) Reactive oxygen species and antioxidants in the pathophysiology of cardiovascular disease: does the actual knowledge justify a clinical approach? Curr Vasc Pharmacol 8:259PubMedCrossRef
193.
Zurück zum Zitat Rivera J, Sobey CG, Walduck AK et al (2010) Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models. Redox Rep 15:50PubMedCrossRef Rivera J, Sobey CG, Walduck AK et al (2010) Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models. Redox Rep 15:50PubMedCrossRef
194.
Zurück zum Zitat Drummond GR, Selemidis S, Griendling KK et al (2011) Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 10:453PubMedCrossRef Drummond GR, Selemidis S, Griendling KK et al (2011) Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 10:453PubMedCrossRef
195.
Zurück zum Zitat Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87PubMedCrossRef Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87PubMedCrossRef
196.
Zurück zum Zitat Kern PA, Ranganathan S, Li C et al (2001) Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280:E745PubMed Kern PA, Ranganathan S, Li C et al (2001) Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280:E745PubMed
197.
Zurück zum Zitat Pradhan AD, Manson JE, Rifai N et al (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327PubMedCrossRef Pradhan AD, Manson JE, Rifai N et al (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327PubMedCrossRef
198.
Zurück zum Zitat Furukawa S, Fujita T, Shimabukuro M et al (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114:1752PubMed Furukawa S, Fujita T, Shimabukuro M et al (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114:1752PubMed
199.
Zurück zum Zitat Soares AF, Guichardant M, Cozzone D et al (2005) Effects of oxidative stress on adiponectin secretion and lactate production in 3T3–L1 adipocytes. Free Radic Biol Med 38:882PubMedCrossRef Soares AF, Guichardant M, Cozzone D et al (2005) Effects of oxidative stress on adiponectin secretion and lactate production in 3T3–L1 adipocytes. Free Radic Biol Med 38:882PubMedCrossRef
200.
Zurück zum Zitat Silver AE, Beske SD, Christou DD et al (2007) Overweight and obese humans demonstrate increased vascular endothelial NAD(P)H oxidase-p47(phox) expression and evidence of endothelial oxidative stress. Circulation 115:627PubMedCrossRef Silver AE, Beske SD, Christou DD et al (2007) Overweight and obese humans demonstrate increased vascular endothelial NAD(P)H oxidase-p47(phox) expression and evidence of endothelial oxidative stress. Circulation 115:627PubMedCrossRef
201.
Zurück zum Zitat Otani H (2011) Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxid Redox Signal 15:1911PubMedCrossRef Otani H (2011) Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxid Redox Signal 15:1911PubMedCrossRef
Metadaten
Titel
Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome?
verfasst von
Saeed R. Khan
Publikationsdatum
01.04.2012
Verlag
Springer-Verlag
Erschienen in
Urolithiasis / Ausgabe 2/2012
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-011-0448-9

Weitere Artikel der Ausgabe 2/2012

Urolithiasis 2/2012 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.